DXS International plc Statement Re Grant Of Nhs Accreditation For Dxs Expertcare
29 June 2021 - 4:00PM
UK Regulatory
TIDMDXSP
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Grant of NHS Accreditation for DXS ExpertCare
DXS International plc ("DXS", the "Company"), the AQSE quoted
clinical decision support developer and supplier of clinical
decision support systems, is delighted to announce the grant of NHS
Digital certification, for DXS ExpertCare, its ground-breaking
digital hypertension medicines optimisation solution.
An open listing on the GP IT Futures online Digital Buying
Catalogue gives GP practices, Clinical Commissioning Groups (CCGs),
or any other NHS primary health systems in the UK the opportunity
to buy rapidly evolving digital e-health tools and services that
are centrally funded.
The NHS regards the GP IT Futures programme as a critical
enabler for taking primary care towards the requirements set out in
the NHS Long Term Plan, the five-year framework for GP contract
reform and the Digital, Data and Technology Vision. It replaces the
contractual framework GP System of Choice (GPSoC) to supply IT
systems and services to GP practices and associated organisations
in England. It is also the first framework from the new Digital
Care Services model.
DXS ExpertCare represents an important breakthrough in primary
care hypertension management and reduces the risk of avoidable
medicines-related consequences. Two-thirds of people with
multimorbidity are hypertensive and treating them is often
complicated. Different conditions and treatments may interact in
complicated ways and cause negative impacts. ExpertCare employs
complex medicines optimisation algorithms with the goal of
mitigating prescribing complexity. It automatically provides
just-in-time prescribing advice to clinicians and healthcare
workers aimed at controlling the patient's blood pressure to an
appropriate target.
The algorithm driving the solution uses a matrix pattern
recognition approach so that the program can calculate the optimum
drug regimen for any combination of comorbid diseases. It then
compares this with the patient's current medication and recommends
a sequence of drug changes to achieve concordance with all Best
Evidence Medicine (BEM) guidelines that apply to an individual
patient.
The ExpertCare solution, that also has CE Class A medical device
certification, is currently being piloted in general practices
across the UK in preparation for commercial release.
David Immelman, Chief Executive of DXS said:
"We are hugely proud of gaining NHS GP IT Future accreditation
for DXS ExpertCare. This solution is a world-first that we believe
has international scalability. Worldwide hypertension is a massive
public health problem that claims millions of lives and drives
health care costs. In England alone, a reduction in avoidable
medicines-related admissions could save the NHS nearly two million
hospital bed days and up to GBP530 million per year.
DXS ExpertCare has an important role to play in making this
possible and should be in the hands of every primary care clinician
in the country. Attaining NHS Digital certification is an important
step in this direction".
The Directors of DXS International plc accept responsibility for
this announcement
Enquiries:
David Immelman (Chief Executive) 01252 719800
DXS International plc david@dxs-systems.com
https://www.dxs-systems.co.uk
Corporate Advisor
City & Merchant
David Papworth 020 7101 7676
Corporate Broker
Hybridan LLP
Claire Louise Noyce 020 3764 2341
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other
trusted NHS sources, to doctors, nurses and pharmacists in their
workflow and during the patient consultation. This effective
clinical decision support ultimately translates to improved
healthcare outcomes delivered more cost effectively and which
should significantly contribute towards the NHS achieving its
projected efficiency savings.
(END) Dow Jones Newswires
June 29, 2021 02:00 ET (06:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
DXS (AQSE:DXSP)
Historical Stock Chart
From May 2024 to Jun 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2023 to Jun 2024